PACB vs RL · rev $38.4M vs P/E 24, rev $8.11B
Pacific Biosciences of California (PACB) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
PACB currently screens at market cap $387.1M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the PACB and RL stock pages for the full models.
Not investment advice.